posted on
Apr 03, 2022 01:04PM

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Message: Re: Debt
narmac, as long as the lights stay on, we remain in business! That's as much as we can hope for under the present circumstances, to inch us closer to several finish lines.
Narmac just keep on buying "ZHCLF" @ $0.15 CAN. With Zenith's Oncology pipeline that's a real bargain. I'm doing it.
https://clinicaltrials.gov/ct2/show/NCT04840589
https://clinicaltrials.gov/ct2/show/NCT04986423#contacts
https://clinicaltrials.gov/ct2/show/NCT03901469
https://clinicaltrials.gov/ct2/show/NCT04471974
https://clinicaltrials.gov/ct2/show/NCT03051659
https://clinicaltrials.gov/ct2/show/NCT05111561
GLTA
Koo
2 Recommendations
Loading...
Loading...
New Message
Please
login
to post a reply